Scientists have created a near-copy of the long-extinct dire wolf. Using advanced CRISPR gene editing tech, it now looks ...

CRISPR Therapeutics is a biotech company that borrows its name from the groundbreaking gene editing technology CRISPR. As of last year, the company has earned FDA approval for a CRISPR-based treatment ...

Genome editing technologies like CRISPR-Cas9 have transformed biology, medicine, and agriculture, but concerns remain about ...

CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and ...

We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on Two Natural Cap’s Substack. In this article, we will ...

Using an inexpensive electrode coated with DNA, MIT researchers have designed disposable diagnostics that could be adapted to ...

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Estimates for CRISPR’s 2025 loss per share have widened from $5.06 to $5.54 in the past 60 days. During the same timeframe, loss per share estimates for 2026 have increased from $3.76 to $4.30.

For decades, researchers have wondered why some people with risky gene variants go on to develop Parkinson’s disease, while others do not. A new study may have just provided the most detailed ...

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...

Medicare eligibility for dummies You'll typically become eligible for Medicare when you turn 65. It's also possible to get Medicare at any age if you have Lou Gehrig's disease (ALS) or kidney failure ...

Turning a $10,000 investment into $1 million represents a financial dream for many — a 100x return that would require an annualized growth rate of approximately 63% over a decade. This level of ...